Posterior reversible encephalopathy syndrome (pres) presenting as transient complete visual Loss by Javed, Nismat et al.
Masthead Logo Pakistan Journal of Neurological Sciences (PJNS)
Volume 14 | Issue 1 Article 1
3-2019
Posterior reversible encephalopathy syndrome
(pres) presenting as transient complete visual Loss
Nismat Javed
Shifa International Hospital. Islamabad, Pakistan
Sohail Naseem
Shifa International Hospital. Islamabad, Pakistan.
Mohammad Amer Awan
Shifa International Hospital, Islamabad
Shahzad Khan Siddique
Shifa International Hospital, Islamabad
Arsalan Ahmad
Shifa International Hospital Islamabad
Follow this and additional works at: https://ecommons.aku.edu/pjns
Part of the Neurology Commons
Recommended Citation
Javed, Nismat; Naseem, Sohail; Amer Awan, Mohammad; Siddique, Shahzad Khan; and Ahmad, Arsalan (2019) "Posterior reversible
encephalopathy syndrome (pres) presenting as transient complete visual Loss," Pakistan Journal of Neurological Sciences (PJNS): Vol.
14 : Iss. 1 , Article 1.
Available at: https://ecommons.aku.edu/pjns/vol14/iss1/1
Posterior reversible encephalopathy syndrome (PRES) is a clinical diagnosis in which patients present with 
combinations of the following signs and symptoms: focal neurologic deficits, headache, seizures and vision loss. It is 
more of a radiological diagnosis as vasogenic edema continues to be one of the many features reported.
Case Report
A 33-year old previously healthy woman, presented to the emergency room with complaints of bilateral vision loss for 
the last 5 hours, 5 days after caesarian section delivery of quadruplets that were conceived using assisted in vitro 
fertilization. After the delivery, she had a persistent headache for 3 to 4 days that was followed by bilateral visual loss 
at 12 noon on the 5th day. She experienced a generalized tonic-clonic seizure at 3 pm the same day and at 4pm that 
resolved after intravenous magnesium sulfate had been administered. At the time of admission, there were no seizures 
and her blood pressure at that time was measured to be 200/120 mm of Hg.  At 9.45 pm, the same day, she 
experienced another generalized tonic-clonic seizure that lasted for 5 to 7 minutes, with loss of consciousness for 20 
minutes after the episode. On examination, her Glasgow Coma Scale was 14/15 and pupils were 4mm, bilaterally 
reactive. She had no perception of light. The power in all four limbs was normal. The plantar response was flexor 
bilaterally. Deep tendon reflexes were 2+ and equal in all 4 limbs. A provisional diagnosis of PRES was made and the 
patient was administered intravenous ceftriaxone, 2g, once daily as empiric treatment in ER. Additionally, the patient 
was later administered intravenous paracetamol, 1g, as needed, intravenous phenytoin, 100 mg, every 8 hours, 
intravenous labetalol, 10mg, every 12 hours and intravenous magnesium sulfate, 4g diluted in 400 ml of normal saline 
at the rate of 133ml/hr. Laboratory work up revealed serum sodium to be 140 mEq/L, potassium to be 3.9 mEq/L and 
a creatinine level of 0.60 mg/dl. The diagnosis was confirmed by MRI findings along with clinical history that showed 
high abnormal signals in bilateral occipital lobes on FLAIR, diffusion weighted axial MRI and a minor hemorrhage was 
revealed on GRE (Figure 1).
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FIGURE 1 (a) and (b). FLAIR images showing high signal areas in bilateral occipital lobes, left more than right
(c). Plain Axial DWI showing diffusion restriction in bilateral occipital lobes, left more than right
(d). GRE image showing microbleed in left occipital lobe
  Fig 2. EEG findings that showed slowing over bilateral occipital lobes
Ophthalmology opinion revealed that there was no retinal damage. The patient had a blood pressure of 150/90 mm 
of Hg, the next day and could count fingers at 6 feet with both of her eyes, showing marked improvement. There was 
response to light and retinal examination was normal. She was discharged on oral amlodipine, 5 mg, twice daily, oral 
labetalol, 100 mg, twice daily, oral phenytoin, 100 mg, thrice daily and oral cefixime, 400 mg, once daily.
Discussion:
Posterior reversible encephalopathy syndrome (PRES) has become a widely recognized disorder. It is known to be 
associated with chronic kidney disease and acute kidney injury1. A theory explaining the pathophysiology of the 
syndrome states that severe hypertension2, 3 interrupts brain autoregulation that leads to hyperperfusion and cerebral 
vessel damage, resulting in extravasation of fluids and proteins producing vasogenic edema3. This process is 
accelerated by endothelial dysfunction caused by systemic inflammatory conditions as sepsis, eclampsia, 
transplantation and autoimmune disease3. The prevalence of this syndrome has not been widely established yet.
This case illustrates that patients PRES may occasionally present with bilateral visual loss4 and seizures particularly in 
patients who are at a higher risk of either pre-eclampsia or eclampsia in antepartum period. The risk of either disorder 
is greatly increased with in vitro fertilization5, 6,  7.
The symptoms resolve with normalization of blood pressure as illustrated by our patient who had marked improvement 
after administration of oral and intravenous anti-hypertensives8 and reversal of vision loss. MRI continues to be the 
gold standard for diagnosis9. The radiological findings include subcortical edema involving parieto-occipital areas10 
which was the case for our patient. 
This case illustrates that the differential diagnosis of posterior reversible encephalopathy syndrome (PRES) should 
always be considered in a post-partum female patient presenting with temporary visual loss and a recent history of in 
vitro fertilization.
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